Profile Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
|T. Rowe Price Associates, Inc.||9.47|
|Fidelity Management & Research Co.||9.06|
|Capital Research & Management Co. (World Investors)||8.99|
|The Vanguard Group, Inc.||6.29|
|Wellington Management Co. LLP||5.82|
|BlackRock Fund Advisors||5.14|
|SSgA Funds Management, Inc.||4.62|
|Columbia Management Investment Advisers LLC||3.11|
|JPMorgan Investment Management, Inc.||3.09|
|ClearBridge Investments LLC||2.94|
|Jennison Associates LLC||2.09|
|Waddell & Reed Investment Management Co.||1.63|
|Northern Trust Investments, Inc.||1.20|
|Goldman Sachs Asset Management LP||1.05|